Skip to main content
Article thumbnail
Location of Repository

Variation in CHI3LI in Relation to Type 2 Diabetes and Related Quantitative Traits

By Camilla Noelle Rathcke, Johan Holmkvist, Torben Jørgensen, Knut Borch-Johnsen, Torben Hansen, Oluf Borbye Pedersen and Henrik Vestergaard
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2674946
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2007). A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker.
    2. (2007). A genome-wide association study of global gene expression.
    3. (2003). A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.
    4. (2005). An immune origin of type 2 diabetes?
    5. (2004). Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
    6. (2004). Creactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    7. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
    8. (2008). Effect of variation in CHI3L1 on serum YKL-40 level,risk ofasthma, and lung function.N
    9. (2005). Efficiency and power in genetic association studies.
    10. (2002). Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population.
    11. (2005). Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q.
    12. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
    13. (2007). Genome-wide association scans for Type 2 diabetes: new insights into biology and therapy.
    14. (1999). Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.
    15. (2003). Growing evidence for diabetes susceptibility genes from genome scan data.
    16. (1995). Identification of a 38-kDa heparinbinding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling.
    17. (1986). In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells.
    18. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.
    19. (2003). Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion.
    20. (2008). Inflammatory markers in relation to insulin resistance and the metabolic syndrome.
    21. (2004). Linkage of the metabolic syndrome to 1q23–q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study.
    22. (2009). Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol.
    23. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses.
    24. (2008). Serum levels of YKL-40 increases in patients with acute myocardial infarction.
    25. (2007). Serum YKL40 levels in patients with coronary artery disease.
    26. (2006). Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.
    27. (2005). The metabolic syndrome.
    28. (2006). YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.
    29. (2009). YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with Type 1 Diabetes and increases with levels of albuminuria. Diabetes Care.
    30. (2006). YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.